Thursday, October 30, 2025

Cresco Labs: Analyst Expectations For Q2 2021

Cresco Labs (CSE: CL) announced that they will be reporting their second quarter financials before the market opens on August 13.

Analysts have a consensus C$23.31 12-month price target on the company, via a total of 17 analysts, with 5 analysts having a strong buy rating, 11 analysts have a buy rating and a single analyst has a hold rating. The street high comes in at a C$36 price target, and the lowest target comes in at a C$13.66 price target.

13 analysts have revenue estimates for the second quarter. The mean between all 13 is $194.72 million; this number has been the same since the start of the year. The street high is $216.20 million while the lowest sits at $187 million.

8 analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 50.65%, with this number being revised slightly higher from 49.25% at the start of the year. Street high goes to Beacon Securities with a 52% estimate and the lowest sits at 50%.

Onto EBITDA estimates, there are currently 131analysts who have second quarter EBITDA estimates. The mean is currently $44.56 million, with this number being lower than at the start of the year. Street high goes to ATB Capital Markets with a $47.30 million EBITDA estimate and the lowest being a $40.99 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver’s Finally Breaking the System | Keith Neumeyer – First Majestic

The Best News for Gold Was the Drop! – Peter Grandich

McEwen Copper: The Los Azules Feasibility Study

Recommended

Silver47 Completes Property-Wide Geochemical, Rock Sampling Program At Adams Plateau, Identifies Numerous Targets

Altamira Gold Identifies Presence Of Second Mineralized Porphyry Body At Cajueiro

Related News

Coinbase: Canaccord Drops Price Target From $342 to $275

On February 24th, Coinbase Global, Inc. (NASDAQ: COIN) reported its fourth quarter financial results. The...

Tuesday, March 1, 2022, 04:56:00 PM

CloudMD: Canaccord Cuts Target To $0.45 Ahead of Q2 2022 Results

On Wednesday, Canaccord Genuity Capital Markets downgraded and cut their price target on CloudMD (TSXV:...

Sunday, August 21, 2022, 03:09:00 PM

Peloton: Analysts Expect $1.11 Billion In Revenue For Q3

Peloton Interactive (NASDAQ: PTON) will be reporting its fiscal third quarter financial results today after...

Thursday, May 6, 2021, 11:06:00 AM

Cameco: Canaccord Refers To Firm As “Go-To” Name For Uranium Exposure

On February 9th, Cameco (TSX: CCO) reported its full-year 2021 financial results. The company reported...

Saturday, February 12, 2022, 02:03:00 PM

BBTV Holdings Sees Canaccord Raise Price Target After Financing

Earlier this week, BBTV Holdings (TSX: BBTV) announced that they closed their upsized 7% convertible...

Saturday, June 19, 2021, 05:14:00 PM